The effect of disease modifying therapies on fatigue in multiple sclerosis

被引：0
|
作者：
Rivera, Samantha Cruz [1 ]
Aiyegbusi, Olalekan Lee [1 ]
Meier, Daniela Piani [2 ]
Dunne, Achille [3 ]
Harlow, Danielle E. [4 ]
Henke, Christian [5 ]
Kamudoni, Paul [5 ]
Calvert, Melanie [1 ]
机构：
[1] Univ Birmingham, Ctr Patient Reported Outcomes Res, Birmingham, W Midlands, England
[2] Ares Trading SA, Eysins, Switzerland
[3] Merck Healthcare KGaA, Darmstadt, Germany
[4] EMD Serono, Billerica, MA USA
[5] Merck KGaA, Darmstadt, Germany
来源：
QUALITY OF LIFE RESEARCH | 2024年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
2072
引用
收藏
页码：S194 / S194
页数：1
相关论文
共 50 条
  • [41] Assessing the risk of multiple sclerosis disease-modifying therapies
    Ayrignac, Xavier
    Bilodeau, Philippe-Antoine
    Prat, Alexandre
    Girard, Marc
    Labauge, Pierre
    Le Lorier, Jacques
    Larochelle, Catherine
    Duquette, Pierre
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2019, 19 (07) : 695 - 706
  • [42] Adherence to disease-modifying therapies in patients with multiple sclerosis
    Koltuniuk, Aleksandra
    Rosinczuk, Joanna
    PATIENT PREFERENCE AND ADHERENCE, 2018, 12 : 1557 - 1565
  • [43] Inequalities in the provisions of disease modifying therapies for multiple sclerosis in the UK
    Evangelou, N.
    Karsay, A.
    Owens, T.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2006, 77 (12): : 1399 - 1399
  • [44] The Use of Oral Disease-Modifying Therapies in Multiple Sclerosis
    Benedikt Kretzschmar
    Hannah Pellkofer
    Martin S. Weber
    Current Neurology and Neuroscience Reports, 2016, 16
  • [45] Current and future disease-modifying therapies in multiple sclerosis
    Lim, S. Y.
    Constantinescu, C. S.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (05) : 637 - 650
  • [46] Disease-modifying therapies and infectious risks in multiple sclerosis
    Winkelmann, Alexander
    Loebermann, Micha
    Reisinger, Emil C.
    Hartung, Hans-Peter
    Zettl, Uwe K.
    NATURE REVIEWS NEUROLOGY, 2016, 12 (04) : 217 - 233
  • [47] Emerging disease-modifying oral therapies for multiple sclerosis
    Losy, Jacek
    Kalinowska-Lyszczarz, Alicja
    JOURNAL OF NEUROIMMUNOLOGY, 2011, 231 (1-2) : 15 - 22
  • [48] Regulation of human glia by multiple sclerosis disease modifying therapies
    Luke M. Healy
    Mackenzie A. Michell-Robinson
    Jack P. Antel
    Seminars in Immunopathology, 2015, 37 : 639 - 649
  • [49] Tuberculosis screening in the setting of multiple sclerosis disease modifying therapies
    Baldassari, L.
    Willis, M. A.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 937 - 938
  • [50] Personalized Use of Disease-Modifying Therapies in Multiple Sclerosis
    Lee, Chi-Yan
    Chan, Koon-Ho
    PHARMACEUTICS, 2024, 16 (01)
12345